Select a community
All Communities
Home > Community Treatment Reports > Glatiramer acetate Treatment Report

See More Treatments

See all treatments in the PatientsLikeMe system shared by patients just like you.


Glatiramer acetate Treatment Report

Brand Names: Copaxone
Generic Name: Glatiramer acetate

What is Glatiramer acetate? Glatiramer acetate combines four amino acids including L-alanine, L-glutamic acid, L-lysine and L-tyrosine. It is used for Relapsing-Remitting Multiple Sclerosis (RRMS) to reduce the frequency and severity of relapses. It is administered as a subcutaneous injection.

See more information, including instructions, precautions, side effects, and interactions.


Dosages

Based on the patients currently taking Glatiramer acetate.

Top 10 (Show all)

All (Show top 10)

  20mg as needed 20mg/mL as needed 20mg weekly daily 1 mL weekly 0.2 mg daily 1 daily 1 g daily 1 mg daily 1 mL daily 2 mg daily 20 mg weekly 5 mg daily 40 mg weekly 10 mg daily 20 mg 20 mg every other day 13 mg daily 15 mg daily 20 daily 20 mcg daily 20 mg daily 20 mg one time 22 mg daily 25 mg daily 30 mg daily 40 mg daily 44 mg daily 50 mg daily 60 mg daily 80 mg daily 81 mg daily 100 mg daily 120 mg daily 200 mg daily 250 mg daily 300 mg daily 1200 mg daily
  2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 241 Number of Patients: 241 1 Number of Patients: 1 1 Number of Patients: 1 6 Number of Patients: 6 1 Number of Patients: 1 42 Number of Patients: 42 3 Number of Patients: 3 2 Number of Patients: 2 3 Number of Patients: 3 2 Number of Patients: 2 1 Number of Patients: 1 12 Number of Patients: 12 1 Number of Patients: 1 25 Number of Patients: 25 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1558 Number of Patients: 1558 1 Number of Patients: 1 1 Number of Patients: 1 5 Number of Patients: 5 7 Number of Patients: 7 8 Number of Patients: 8 3 Number of Patients: 3 3 Number of Patients: 3 6 Number of Patients: 6 1 Number of Patients: 1 1 Number of Patients: 1 3 Number of Patients: 3 1 Number of Patients: 1 9 Number of Patients: 9 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Duration

How long current patients have been taking Glatiramer acetate or how long patients were taking Glatiramer acetate before stopping.

Currently Taking Glatiramer acetate

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
7
32
90
203
203
398

Stopped Taking Glatiramer acetate

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
34
68
97
136
127
217
Why Patients Stopped Taking Glatiramer acetate (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work 288 40% Did not seem to work: 40%
Side effects too severe 250 35% Side effects too severe: 35%
Doctor's advice 190 26% Doctor's advice: 26%
Other 145 20% Other: 20%
Expense 53 7% Expense: 7%
Personal research 32 4% Personal research: 4%
Not indicated 12 2% Not indicated: 2%
Course of treatment ended 7 1% Course of treatment ended: 1%

Patient Reported Evaluations

Results from 488 patient evaluations. See the overall results and all individual evaluations.

Efficacy (Effect based on reason taken)

Major 16% 69
Moderate 15% 68
Slight 9% 39
None 7% 29
Can't tell 54% 238

Slow my MS progress

Side-effects (as an overall problem)

Severe 9% 43
Moderate 15% 73
Mild 50% 245
None 26% 127

Top reported side-effects include: lumps, Injection site reaction, redness

Summary results are based on 488 individual responses. For more information, see overall results for Adherence, Burden and Cost.

Individual Patient Reported Evaluations (2 of 488)

  • BrainStain4
    Sex: F
    Flare-up: Moderate
    Sensation: Moderate
    Overall: None
    Cognition: none
    Vision: none
    Speech: none
    Swallowing: none
    Upper limb: moderate
    Walking: moderate
  • BrainStain4
  • by BrainStain4
    Aug 18, 2008
  • EfficacyCan't tell
  • Side-effectsMild
  • Slow my MS progress
Advice/Tips
Doing the injections manually (rather than using the autoject) results in less site reactions. Read the included information, and make sure you are aware of the symptoms of the "reaction" that some experience immediately after injecting. It can be really scary when it happens if you don't know what it is. It happened to me once, after being on Copaxone for over 1.5 years.

  • JesswithMS
    Sex: F
    Sensation: Moderate
    Overall: Moderate
    Cognition: moderate
    Vision: moderate
    Speech: moderate
    Swallowing: moderate
    Upper limb: moderate
    Walking: moderate
  • JesswithMS
  • by JesswithMS
    Feb 10, 2005
  • EfficacyModerate
  • Side-effectsMild
  • Slow my MS progress
Advice/Tips
Ice down your injection site to help with the redness. I also found that self injecting prevented the welts I would get from the autoinjector.

See all evaluation results for Glatiramer acetate

Report created on November 07, 2009.